Valuation: AstraZeneca PLC

Capitalization 231B 220B 208B 183B 327B 20,036B 363B 2,469B 915B 8,364B 864B 847B 34,985B P/E ratio 2025 *
22.9x
P/E ratio 2026 * 19.7x
Enterprise value 250B 239B 225B 198B 354B 21,681B 393B 2,671B 990B 9,051B 935B 917B 37,858B EV / Sales 2025 *
4.36x
EV / Sales 2026 * 3.98x
Free-Float
96.62%
Yield 2025 *
2.16%
Yield 2026 * 2.28%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.63%
1 week+0.60%
Current month+3.91%
1 month+7.77%
3 months+18.14%
6 months-9.64%
Current year+12.61%
More quotes
1 week
11 580.00
Extreme 11580
12 060.00
1 month
10 790.00
Extreme 10790
12 060.00
Current year
10 314.00
Extreme 10314
12 060.00
1 year
9 670.00
Extreme 9670
13 388.00
3 years
8 326.00
Extreme 8326
13 388.00
5 years
5 871.00
Extreme 5871
13 388.00
10 years
3 680.00
Extreme 3680
13 388.00
More quotes
Manager TitleAgeSince
Chief Executive Officer 64 2012-09-30
Director of Finance/CFO 51 2021-07-31
Chief Tech/Sci/R&D Officer 57 2019-12-31
Director TitleAgeSince
Director/Board Member 69 1999-04-05
Director/Board Member 64 2012-09-30
Director/Board Member 64 2017-04-26
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi.($)
+0.63%+0.60%+16.78%+32.18% 229B
+1.53%-0.90%+9.61%+256.71% 760B
-0.74%-0.73%-1.00%-5.12% 376B
+3.09%-4.61%-31.01%+74.47% 355B
+1.75%+2.30%+10.57%+36.26% 340B
+0.20%+1.48%+29.23%-14.52% 262B
+0.34%-3.76%-34.82%+9.06% 210B
+0.45%-0.79%+8.74%+20.24% 210B
+0.56%-1.30%+3.21%+32.63% 156B
+0.12%+0.12%-7.46%-47.33% 145B
Average +0.64%-1.03%+0.38%+39.46% 304.45B
Weighted average by Cap. +0.90%-1.12%+1.63%+78.83%
See all sector performances

Financials

2025 *2026 *
Net sales 57.27B 54.75B 51.65B 45.4B 81.27B 4,976B 90.17B 613B 227B 2,077B 215B 210B 8,689B 60.73B 58.05B 54.77B 48.13B 86.17B 5,276B 95.6B 650B 241B 2,203B 228B 223B 9,213B
Net income 10B 9.56B 9.02B 7.92B 14.18B 868B 15.74B 107B 39.68B 363B 37.46B 36.72B 1,517B 11.81B 11.29B 10.65B 9.36B 16.76B 1,026B 18.6B 126B 46.88B 428B 44.27B 43.39B 1,792B
Net Debt 18.94B 18.1B 17.08B 15.01B 26.87B 1,645B 29.81B 203B 75.16B 687B 70.97B 69.56B 2,873B 11.31B 10.81B 10.2B 8.96B 16.05B 983B 17.81B 121B 44.89B 410B 42.39B 41.55B 1,716B
More financial data * Estimated data
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Employees
89,900
Calendar
More about the company
Date Price Change Volume
25-02-18 11,788.00 p +0.63% 1,256,095
25-02-17 11,714.00 p +0.05% 719,403
25-02-14 11,708.00 p -2.14% 3,001,390
25-02-13 11,964.00 p +1.37% 4,659,511
25-02-12 11,802.00 p +1.53% 4,282,148

Delayed Quote London S.E., February 18, 2025 at 11:35 am

More quotes
Trading Rating
Investor Rating
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
21
Last Close Price
148.72USD
Average target price
177.32USD
Spread / Average Target
+19.23%
Consensus

Quarterly revenue - Rate of surprise